References
- Billington WD. The immunological problem of pregnancy: 50 years with the hope of progress. A tribute to Peter Medawar. J. Reprod. Immunol.60, 1–11 (2003).
- Hahn S, Gupta AK, Troeger C, Rusterholz C, Holzgreve W. Disturbances in placental immunology: ready for therapeutic interventions? Springer Semin. Immunopathol.27, 477–493 (2006).
- Le Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem. Soc. Trans.28, 208–212 (2000).
- Hunt JS, Vassmer D, Ferguson TA, Miller L. Fas ligand is positioned in mouse uterus and placenta to prevent trafficking of activated leukocytes between the mother and the conceptus. J. Immunol.158, 4122–4128 (1997).
- Uckan D, Steele A, Wang BY et al. Trophoblasts express Fas ligand: a proposed mechanism for immune privilege in placenta and maternal invasion. Mol. Hum. Reprod.3, 655–662 (1997).
- Sedlmayr P, Blaschitz A, Wintersteiger R et al. Localization of indoleamine 2,3-dioxygenase in human female reproductive organs and the placenta. Mol. Hum. Reprod.8, 385–391 (2002).
- Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science270, 630–633 (1995).
- Basten A, Fazekas de St Groth B. Special regulatory T-cell review: T-cell dependent suppression revisited. Immunology123, 33–39 (2008).
- Terness P, Kallikourdis M, Betz AG, Rabinovich GA, Saito S, Clark DA. Tolerance signaling molecules and pregnancy: IDO, galectins, and the renaissance of regulatory T cells. Am. J. Reprod. Immunol.58, 238–254 (2007).
- Santner-Nanan B, Peek MJ, Khanam R et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J. Immunol.183(11), 7023–7030 (2009).
- Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science308, 1592–1594 (2005).
- Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T-cell subset. Immunology112, 38–43 (2004).
- Levine RJ, Lam C, Qian C et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med.355, 992–1005 (2006).
- Venkatesha S, Toporsian M, Lam C et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med.12, 642–649 (2006).
- Steinborn A, Haensch GM, Mahnke K et al. Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin. Immunol.129, 139–145 (2008).
- Gadina M, O’Shea JJ. Immune modulation: turncoat regulatory T cells. Nat. Med.15, 1365 (2009).